Ecuador vs Guinea-Bissau: Reported cases of paralytic polio by world region
Ecuador
0 cases
in 2023
Guinea-Bissau
0 cases
in 2023
Ecuador rank
26th
Guinea-Bissau rank
26th
Reported cases of paralytic polio by world region over time
- Ecuador
- Guinea-Bissau
How they compare
Ecuador currently reports 0 cases against 0 cases in Guinea-Bissau, a difference of 0 cases.
The two have swapped places 5 times across 43 shared years of data; in 1980 it was Ecuador ahead.
Ecuador ranks 26th and Guinea-Bissau ranks 26th of 199 countries.
Guinea-Bissau has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Ecuador | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 8.5 cases | 27 cases | 18.5 cases | Guinea-Bissau |
| 1990s | 0.1111 cases | 0.3333 cases | 0.2222 cases | Guinea-Bissau |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0 cases | 0 cases | 0 cases | — |
| 2020s | 0 cases | 0.75 cases | 0.75 cases | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Ecuador or Guinea-Bissau?
- Ecuador, at 0 cases against 0 cases in Guinea-Bissau as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Ecuador and Guinea-Bissau?
- 0 cases, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Guinea-Bissau?
- 43 years are reported by both, from 1980 to 2023.
- How do Ecuador and Guinea-Bissau rank globally for reported cases of paralytic polio by world region?
- Ecuador ranks 26th and Guinea-Bissau ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.